Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma

Background: This study assesses the feasibility of producing hyperimmune anti-COVID-19 intravenously administrable immunoglobulin (C-IVIG) from pooled convalescent plasma (PCP) to provide a safe and effective passive immunization treatment option for COVID-19. Materials & methods: PCP was fracti...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Immunotherapy
Päätekijät: Ali, Shaukat, Uddin, Syed M, Ali, Ayesha, Anjum, Fatima, Ali, Rashid, Shalim, Elisha, Khan, Mujtaba, Ahmed, Iqra, M Muhaymin, Sheikh, Bukhari, Uzma, Luxmi, Shobha, Khan, Abdul S, Quraishy, Saeed
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Future Medicine Ltd 2021
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7871744/
https://ncbi.nlm.nih.gov/pubmed/33557591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt-2020-0263
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia